drugset / Trial / NCT01603836

Study Confirms or Refutes the Hypothesis That the Autologous Bone Marrow Concentrate Together With the Allograft is a Better Alternative for the Posterolateral Fusion in Spine Surgery Than the Allograft Alone

NCT01603836

Completed 80 enrolled Hospital Znojmo
Parallel-groupSingle-blindTreatment

Summary

The use of autologous mesenchymal stem cell (MSCs) in form of the BMC in combination with allograft is an effective option how to enhance the Posterolateral Fusion (PLF) healing. Allograft by itself is not an effective material as a posterior onlay graft for the PLF in adult surgery.

Timeline

Start
2009-02
Primary completion
2010-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bone Marrow Concentrate Cell therapy
Background spongious allograft chips Unknown

Indications